| PERIOD ENDING | 31-Dec-03 | 31-Dec-02 | 31-Dec-01 | | Total Revenue | 1,045 | 5,372 | 9,048 | | Cost of Revenue | 2,239 | 7,796 | 7,857 | | | Gross Profit | (1,194) | (2,424) | 1,191 | | | Operating Expenses | | Research Development | 971 | 2,759 | 4,335 | | Selling General and Administrative | 1,976 | 6,384 | 7,518 | | Non Recurring |
-
| 15,257 |
-
| | Others | 576 | 772 | 2,832 | | | | Total Operating Expenses |
-
| 25,173 |
-
| | | | Operating Income or Loss | (4,716) | (27,596) | (13,494) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13 | 224 | 277 | | Earnings Before Interest And Taxes | (4,703) | (27,372) | (13,217) | | Interest Expense | 47 |
-
|
-
| | Income Before Tax | (4,749) | (27,372) | (13,217) | | Income Tax Expense |
-
| (200) |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,749) | (27,172) | (13,217) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,749) | (27,172) | (13,217) | | Preferred Stock And Other Adjustments | (18) | (636) | (7,710) | | | Net Income Applicable To Common Shares | ($4,767) | ($27,808) | ($20,926) |
|
0.18% Nasdaq 
0.07%
Income Statement
